tradingkey.logo
tradingkey.logo
검색

라이프밴티지(LFVN) 2026 회계연도 4분기 실적 발표: 매출 23.1% 감소, 2027 회계연도 가이던스 미제시

TradingKeyAug 27, 2026 10:01 PM
facebooktwitterlinkedin
모든 코멘트 보기0

라이프밴티지의 2026 회계연도 4분기 순매출은 주문 건수 감소와 마인드바디 GLP-1 시스템 매출 약세 등으로 전년 동기 대비 23.1% 감소한 4,240만 달러를 기록했다. GAAP 순이익은 130만 달러, 조정 EBITDA는 270만 달러로 집계되었다. 회사는 차입금 없이 1,490만 달러의 현금을 보유하고 있다. 신임 CEO 취임에 따른 전략 점검으로 2027 회계연도 공식 가이던스는 제시되지 않았으며, 경영진은 상반기 동안 기저효과 부담이 이어질 것으로 예상하고 있다. 수립 중인 전략을 통해 하반기 모멘텀이 개선될 것으로 기대하고 있으나, 이는 확정된 예측이 아닌 목표 수준으로 언급되었다.

AI 생성 요약

핵심 요약

  • 2026 회계연도 4분기 순매출은 주문 건수 감소, 평균 주문 금액 하락, 전년 동기의 견조한 실적에 따른 기저효과 속 마인드바디(MindBody) GLP-1 시스템 매출 약세로 인해 전년 동기 대비 23.1% 감소한 4,240만 달러를 기록했으며, 전분기 대비로는 3.1% 감소했습니다.
  • GAAP 순이익은 130만 달러(희석 주당순이익 0.10달러)로 감소했습니다. 조정 순이익은 140만 달러(희석 주당순이익 0.11달러)를 기록했습니다.
  • 조정 EBITDA는 전년 동기 480만 달러(매출의 8.7%)에서 감소한 270만 달러(매출의 6.5%)를 기록했습니다.
  • 구독 기반 매출은 분기 매출의 75% 이상을 유지했으며, 고객 유지 지표는 전년 동기 대비 개선되었습니다.
  • 라이프밴티지(LifeVantage)는 부채 없이 1,490만 달러의 현금을 보유한 채 2026 회계연도를 마무리했습니다. 회계연도 전체 영업활동 현금흐름은 총 1,020만 달러를 기록했습니다.
  • 회사는 CEO 교체 이후 공식적인 2027 회계연도 실적 전망(가이던스)을 제시하지 않았습니다. 경영진은 회계연도 1분기와 2분기에는 기저효과로 인한 어려움이 이어질 것으로 예상하며, 수립 중인 전략을 통해 3분기와 4분기에는 모멘텀이 개선되기를 기대하고 있습니다.

주요 재무 데이터

지표2026 회계연도 4분기2025 회계연도 4분기변동 및 상세 맥락
순매출4,240만 달러5,510만 달러전년 동기 대비 23.1% 감소, 전분기 대비 3.1% 감소
미주 지역 매출3,270만 달러전년 동기 대비 24.8% 감소
아시아·태평양 및 유럽 지역 매출970만 달러전년 동기 대비 16.9% 감소
매출총이익률78.0%79.9%제품 믹스 변화, 재고자산 진부화, 배송 및 창고 비용 증가로 인해 하락
수수료 및 인센티브 비용매출의 41.3%42.1%프로모션 시기 및 판매 믹스 변화 반영
GAAP 판매관리비매출의 32.7%33.9%매출 대비 비중 감소
조정 판매관리비매출의 32.3%33.3%변동 보수 및 행사 비용 감소 효과 반영
GAAP 영업이익170만 달러210만 달러전년 동기 대비 감소
조정 영업이익180만 달러250만 달러전년 동기 대비 감소
GAAP 순이익130만 달러200만 달러희석 EPS 0.10달러(전년 동기 0.15달러 대비 감소)
조정 순이익140만 달러230만 달러조정 희석 EPS 0.11달러(전년 동기 0.17달러 대비 감소)
조정 EBITDA270만 달러480만 달러이익률 6.5%(전년 동기 8.7% 대비 하락)

회계연도 말 기준 라이프밴티지의 현금 보유액은 1,490만 달러로 전년 동기의 2,020만 달러 대비 감소했으나 차입금은 없었습니다. 2026 회계연도 영업활동 현금흐름은 1,020만 달러로 2025 회계연도의 1,190만 달러 대비 감소했습니다. 설비투자(CAPEX)는 쇼피파이(Shopify) 연동을 포함한 기술 인프라 투자 확대를 주로 반영해 140만 달러에서 360만 달러로 증가했습니다.

라이프밴티지는 2026 회계연도 중 러브 바이옴(Love Biome) 인수 거래에 370만 달러를 사용했습니다. 또한 4분기의 약 45만 9,000달러 규모 8만 5,700주를 포함해 총 200만 달러 규모로 약 33만 6,000주를 자사주 매입했습니다. 회사는 주당 0.05달러의 분기 배당금을 선언했으며, 2026년 9월 1일 기준 주주를 대상으로 2026년 9월 15일에 지급될 예정입니다.

사업 및 운영 실적

매출 압박은 활성 계정의 주문 건수 감소와 평균 주문 규모 하락을 반영했습니다. 경영진은 마인드바디(MindBody)가 고가 제품군에 속하는 데다 강세를 보였던 2025 회계연도 4분기 대비 매출이 감소하면서 평균 주문 금액에 영향을 미쳤다고 밝히고 있습니다. 또한 다른 제품 카테고리에서도 완만한 평균 주문 금액 약세가 나타났습니다.

2025년 10월 인수한 러브 바이옴(Love Biome)이 매출 감소를 일부 상쇄했습니다. 또한 경영진은 충성 고객들의 구매는 지속되고 있으나, 일부 고객이 구독을 한 달간 일시 중단했다가 재개하는 경향이 관측되었다고 덧붙였습니다.

신임 CEO인 테렌스 무어헤드(Terrence Moorehead)는 초기 3대 우선 과제로 라이프밴티지 브랜드 강화, 보다 적합한 소비자 가치 제안 창출, 운영 실행력 및 수익성 개선을 제시했습니다. 계획된 이니셔티브에는 웹사이트 및 고객 경험 개편, 영업 조직을 위한 디지털 툴 확대, 제품의 과학적 기반과 가치의 보다 명확한 전달 등이 포함됩니다.

해외 시장 확장은 여전히 기회 요인이지만, 경영진은 더 넓은 지역으로 진출하기 전에 북미와 일부 해외 앵커 시장을 포함한 기존 시장에서의 침투율을 높이는 데 우선순위를 둘 계획입니다.

경영진 실적 전망(가이던스)

라이프밴티지는 최근 진행된 CEO 교체와 현재 진행 중인 전략 점검으로 인해 공식적인 2027 회계연도 가이던스를 제공하지 않았습니다.

경영진은 2027 회계연도 1분기와 2분기가 전년 동기 대비 높은 기저효과 부담을 안고 있다고 언급했습니다. 현재 수립 중인 브랜드, 소비자 및 디지털 전략을 통해 3분기와 4분기부터 실적 추세가 개선되기 시작할 수 있을 것으로 기대하고 있으나, 이는 확정된 예측이라기보다는 목표 수준으로 제시되었습니다.

2027 회계연도 설비투자는 쇼피파이 프로젝트의 남은 단계를 완료함에 따라 약 300만~350만 달러 수준이 될 것으로 예상됩니다. 프로젝트가 완료된 이후 경영진은 연간 설비투자가 과거 수준인 200만~250만 달러로 복귀할 것으로 보고 있습니다.

리스크 및 주요 점검 사항

  • 거시경제 및 소비자 물가 압박이 주문 빈도와 평균 주문 규모에 영향을 미치고 있습니다.
  • 마인드바디 매출이 전년 동기 기저효과 부담에 직면하면서 매출 및 주문 금액을 제약하고 있습니다.
  • 매출총이익률은 제품 믹스 변화, 재고자산 진부화, 배송 및 창고 비용 증가로 인해 압박을 받았습니다.
  • 매출이 전년 동기 대비 및 전분기 대비 모두 감소한 가운데, 경영진은 2027 회계연도 상반기까지 기저효과로 인한 어려움이 이어질 것으로 예상하고 있습니다.
  • 성장 전략이 아직 수립 중이며, 경영진은 측정 가능한 재무 목표나 공식적인 2027 회계연도 가이던스를 아직 발표하지 않았습니다.

애널리스트 질의응답(Q&A) 핵심 요약

매출 안정화에 대한 질문에 경영진은 주문 건수 감소와 평균 주문 금액 하락으로 인해 4분기 매출이 3분기 대비 약 150만 달러 적었다고 설명했습니다. 회사는 2027 회계연도 전반기 두 분기 동안 높은 기저효과 부담이 지속될 것으로 예상하며, 새로운 전략이 시행됨에 따라 연말경 모멘텀 회복을 목표로 하고 있습니다.

가격 압박 질문에 대해 무어헤드 CEO는 단순히 가격을 인하하기보다는 가치 제안을 강화할 계획이라고 말했습니다. 전략은 제품 혜택을 보다 효과적으로 전달하고 소비자 연관성을 높이는 데 초점을 맞출 예정입니다.

경영진은 디지털 역량을 핵심 우선 과제로 꼽았습니다. 계획된 투자에는 개편된 웹사이트, 개선된 고객 접점, 영업 인력이 보다 효과적으로 마케팅할 수 있도록 돕는 디지털 툴이 포함됩니다.

해외 성장에 대해 무어헤드 CEO는 라이프밴티지가 북미와 해외 시장 모두에서 아직 침투율이 낮다고 말했습니다. 단기적 접근 방식은 수많은 신규 국가로 즉각 확장하기보다 앵커 시장 기반의 거점형(hub-and-spoke) 모델을 통해 엄선된 기존 시장에서의 침투를 심화하는 것입니다.

실적 발표 전화회의(Earnings Call) 전문


전체 실적 발표 컨퍼런스 콜 녹취록

경영진 발표

Operator

Thank you. Good day, ladies and gentlemen. Thank you for standing by. Welcome to DataAge's conference call to discuss LifeVantage's fourth quarter and fiscal year 2026 results. At this time, all participants are in a listen-only mode. Following the formal remarks, we'll conduct a question and answer session. will be provided at that time for you to queue up. Hosting today's conference will be Reed Anderson with ICR. As a reminder, today's conference is being recorded and I.

Reed Anderson

I would now like to turn the conference over to Mr. Anderson. Please go ahead, sir. Thank you and good afternoon, everyone, and welcome to LifeVantage Corporation's conference call to discuss results for the fourth quarter and full fiscal year 2026. the call today from LifeVantage are Terrence Moorhead, President and Chief Executive Officer, and Carl Alray, Chief Financial Officer. By now, everyone should have access to the earnings release, which went out this afternoon at approximately 4.05 p.m. Eastern Time. If you have not received the release, it is available on the investor relations portion of LifeVantage site at www.lifevantage.com. This call is being webcast and a replay will be available on the company's website as well. Before we begin, we'd like to remind everyone that our prepared remarks contain forward-looking statements, and management may make additional forward-looking statements in response to your questions. These statements do not guarantee future performance, and therefore undue reliance should not be placed upon them.

Thank you. statements are based on current expectations of the company's management, involve inherent risks and uncertainties, including those identified in the risk factor section of life advantages most recently filed, forms 10-K and 10-Q. Please note that during today's call, we will discuss non-GAAP financial measures, including results on an adjusted basis. Management believes these financial measures can facilitate a more complete analysis and greater transparency to LifeVantage's ongoing results of operations, particularly when comparing underlying operating results from period to period. We've included a reconciliation of these non-GAAP measures with today's release. This call also contains time-sensitive information. that is accurate only as of the date of this live broadcast, August 27th, 2026. LifeVantage assumes no obligation to update any forward-looking projections that may be made in today's release or call. Now I will turn the call over to Terrence Moorhead, President and Chief Executive Officer of LifeVantage.

Terrence Moorehead

Thank you, Reid, and good afternoon, everyone. Before we begin, I want to take a moment to thank Michael Beindorf for his stewardship of the business and recognize our leadership team for their support during this transition. Michael stepped in to take on the leadership role, and on behalf of the board of directors, I want to thank him for his leadership. With that, I'd like to say that it's truly a privilege to join you today as Chief Executive Officer of LifeVantage. Since joining the company, I've been immersed in the business, meeting employees, talking with our sales organization and customers, reviewing processes, evaluating capabilities, and assessing our position in the market. It's only been a few weeks, but my conviction about this company is stronger today than when I accepted the role. What attracted me to LifeVantage was the company's differentiated science, solid balance sheet and economics, and significant untapped potential.

Specifically, I believe the company's differentiated science is a critical linchpin to our future success. LifeVantage occupies a unique position in the health and wellness industry, focused on delivering a scientifically grounded platform that helps activate the body's natural biological processes. There are a lot of supplement companies on the market, but there aren't a lot of companies like LifeVantage whose products actually help our bodies do what they're naturally built to do instead of just supplementing our diets. That's a meaningful and powerful distinction, and I believe it gives LifeVantage a real competitive advantage that we intend to leverage. As I look at LifeVantage through a more consumer-focused lens, I see an opportunity for us to build a larger, stronger, more relevant brand. We have compelling science, differentiated products, strong margins, and are targeting a passionate group of consumers that are looking for new ways to improve their health every single day. Those are important building blocks that can create substantial value when paired with focused brand building, disciplined execution, and and a consumer-centric growth strategy.

My initial impression is that the opportunity in front of us is about unlocking the company's potential by reimagining key aspects of the business. We have an opportunity to revitalize our positioning, reframe how consumers think about our brand, strengthen product storylines, and create a greater understanding of the value of our products. Coming out of the blocks, our early focus will be centered around three priorities. First, strengthening the LifeVantage brand. We have valuable science and differentiated products, but I believe we can do a much better job of communicating our story in a more clear, compelling, and consumer-friendly way. Consumers gravitate towards brands they trust and understand. Building that connection consistently and at scale will be a major focus. Our second priority focuses on building a more relevant consumer proposition.

Here, our goal is to arm our sales force with more powerful tools, dramatically improve the consumer experience, and create a larger base of loyal consumers who incorporate LifeVantage in their lives on a daily basis. Our third and final priority will focus on improving operational excellence and profitability. One of the things that immediately stood out to me about LifeVantage were the economics of the business, particularly the gross margins that have historically approached 80% and could create strong opportunities. The challenge will be to effectively translate those economics into sustainable growth and improved shareholder value. Now, I want to be thoughtful about expectations. It's still early in my tenure, so we're not going to be providing any formal guidance at this time. Over the next several months, we'll continue to assess the business and work closely with our leadership team to develop a comprehensive growth strategy supported by clear priorities, measurable objectives, and accountability throughout the organization.

What I can tell you today is that I accepted this role because I believe this company has far greater potential than its current scale reflects. I believe in the potential of our brand. I believe in the quality of our products. And I believe in the people behind this business. We have meaningful work ahead of us, but I'm confident that we have what it takes to create long-term value for our sales force, our employees, and our shareholders. I look forward to sharing more about our plans as the work progresses. And with that, I'd like to turn the call over to our Chief Financial Officer, Carl Oury, so he can walk you through our financial results in more detail.

Carl?.

Unknown Speaker

Thank you, Terrence, and good afternoon, everyone. Let me walk you through our fourth quarter financial results. Please note that I will be discussing our non-GAAP adjusted results where applicable. You can refer to the GAAP to non-GAAP reconciliations in today's press release for additional details. FOR THE FOURTH QUARTER OF FISCAL 2026, WE DELIVERED NET REVENUE OF 42.4 MILLION, WHICH WAS DOWN 23.1% COMPARED TO 55.1 MILLION IN THE FOURTH QUARTER OF FISCAL 2025. The decrease was primarily driven by downward pressure in the number of orders from our active account base and lower average order size, reflecting impacts from the broader macroeconomic environment, as well as lower sales of our mind-body GLP-1 system cycling the higher comparable fourth quarter of fiscal 2025 and partially offset by sales of Love Biome, which we acquired in October of 2025. Fourth quarter revenue was down 3.1% sequentially from the third quarter of fiscal 2026.

Revenue in the Americas region decreased 24.8% to $32.7 million, and revenue in the Asia-Pacific and Europe region decreased 16.9% to $9.7 million. Subscription-based revenue remains strong, representing more than 75% of our total revenue in the fourth quarter of fiscal 2026, and our customer retention metrics improved year over year. We will continue to look for opportunities to improve our retention metrics for our most loyal customers. As Terrence mentioned earlier, we will also look to strengthen the LifeVantage brand and refine our consumer proposition to expand appeal to new consumers. This will be an area of focus for us as we move forward into fiscal 2027. Our gross profit percentage for the fourth quarter was 78% compared to 79.9% in the prior year period, reflecting a shift in product mix, higher inventory obsolescence expenses, and increases in shipping and related warehouse expenses. Commission's incentive expense was 41.3% of revenue compared to 42.1% a year ago, reflecting the timing and magnitude of our promotional incentive programs and changes to the sales mix between customers and independent consultants.

Selling general and administrative expenses were 32.7% of revenue compared to 33.9% in the prior year period. adjusted non-GAAP SG&A was 32.3% of revenue compared to 33.3% in the prior year period, reflecting decreases in variable employee compensation expenses and lower event-related expense. Gap operating income was $1.7 million compared to $2.1 million in the prior year period. Adjusted non-gap operating income was $1.8 million compared to $2.5 million a year ago. Gap net income was 1.3 million or 10 cents per diluted share compared to 2 million or 15 cents per diluted share in the fourth quarter of fiscal 2025. Adjusted non-gap net income was 1.4 million or 11 cents per diluted share compared to 2.3 million and 17 cents in the prior year period. We recorded income tax expense of just over $400,000 in the fourth quarter of fiscal 2026. Our overall effective tax rate for fiscal 2026 was approximately 16.4%.

Adjusted EBITDA in the fourth quarter was $2.7 million, or 6.5% of revenue, compared to $4.8 million, or 8.7% of revenue in the same period a year ago. Our financial position remains strong, with $14.9 million of cash and no debt at the end of fiscal 2026, compared to $20.2 million of cash a year ago. We generated 10.2 million of cash from operations during fiscal 2026 compared to 11.9 million in the prior year period. We also maintain access to a $5 million revolving line of credit. Capital expenditures total $3.6 million in fiscal 2026 compared to $1.4 million in 2025, reflecting our continued investment in technology infrastructure, including the Shopify integration. We also utilized $3.7 million in cash during fiscal 2026 for the Love Biome transaction. Turning to capital allocation, we repurchased 85,700 shares in the fourth quarter for an aggregate purchase price of approximately 459,000.

During fiscal 2026, we repurchased approximately 336,000 shares for an aggregate purchase price of $2 million. As of June 30th, there was $58.5 million remaining under the new $60 million share repurchase authorization approved by our board of directors in January. We also recently announced a quarterly cash dividend of $0.05 per share of common stock that will be paid on September 15, 2026 to shareholders of record as of September 1, 2026. We remain committed to our balanced capital allocation strategy in order to maximize shareholder value. Given the recent transition in our Chief Executive Officer role, we are not issuing formal guidance for fiscal 2027 on today's call. And with that, let me turn the call back over to Terrence.

Terrence Moorehead

Before we open the call for questions, I'd like to leave you with some final thoughts. First, despite the challenges reflected in our recent results, I'm very optimistic about the future of LifeVantage. The more I learn about the company, the more convinced I am that we have a unique opportunity and significant white space ahead. Second, because we have a strong financial foundation driven by our debt-free balance sheet, a healthy cash position, and a disciplined approach to capital allocation, we have the flexibility to invest in growth while continuing to return capital to shareholders. Third and finally, we're going to move forward with a sense of urgency. Over the coming months, we'll be working as a team to develop a clear strategic roadmap, establish measurable goals, and align our organization around execution. In closing, I'm very excited about the future and the potential that lies ahead.

Now, our focus is on building the brand, accelerating consumer relevance, and executing with discipline so we can fully realize that potential.

Operator

With that, let's open the line for questions. Thank you. We'll now be conducting a question and answer session. If you'd like to ask a question, please press star one on your telephone keypad. A confirmation tone will indicate your line is in the question queue. You may press star 2 to remove your question from the queue. For participants using speaker equipment, it may be necessary to pick up the handstand before pressing the star keys. One moment please while we poll for questions.

Thank you. Our first question is from Ryan Myers with Lake Street Capital.

질의응답

Ryan Meyers

Hey guys, thanks for taking my questions. Terrence, congrats on the new role. We're just thinking about the revenue side of the business. You know, we saw another sequential decline here in the fourth quarter. Can you maybe just talk about the monthly trends throughout the quarter and maybe what you've seen so far in July and August and understand that you're not giving back? But have we seen sort of a stabilization? Have trends improved a little bit? Just any commentary there would be helpful.

Unknown Speaker

I'm going to let Carl handle that one. Yes, happy to take that, Ryan. Yes, as you mentioned, sequentially we were down just about $1.5 million or so from Q3 into Q4. You know, some of that we've mentioned, we've talked about some of the challenges we face just with declining orders, number of orders that are out there, as well as just we're seeing a little bit of a decline in just the average order size between Q3 and Q4. we look forward, we're not giving guidance obviously for fiscal 2027, but as you know, looking back at the comparables, we still have a couple of difficult comparables in Q1 and Q2 of our fiscal year next year, and so those will certainly be challenging, but I think as we start to work through the strategies that Terrence and the team are working on here. When we get to our fiscal Q3 into Q4, that's really where we anticipate that we hopefully can turn the trend line and really start to see a little bit of momentum associated with those strategies that we're working on and look to be putting in place at the first part of the year.

Ryan Meyers

Okay, got it. And then thinking about the fewer orders and the lower average order size that you had mentioned, did these come specifically from MindBody? Did they come from the broader portfolio, just as we sort of attribute some of these software KPIs? Was it portfolio?.

Unknown Speaker

I can tell you as a whole, there's certain areas that are down. Yes, no, I can talk to some of that. I mean, MindBody definitely has an impact since MindBody was a higher priced product. So there is certainly some impact from shift away from mind-body on the average order size. But we also are seeing just some decline in the overall average order size in some of the other categories, not significantly so. know, and I think also what we're seeing is we're still, you know, our base of loyal customers. We're seeing that base continue to purchase, but, you know, possibly we're seeing, you know, possibly they're pausing a subscription for a month and then picking it up the next month. And so some of that or all of those things are impacting those metrics at the end of the day.

I think there's a fair amount of price pressure that.

Terrence Moorehead

our consumers under right now, just given what's happening in the economy. And so a couple of our strategies going forward will be looking at how we can strengthen our value proposition, not necessarily by dropping prices, but adding credence to the voice that we have when we're talking about about our products in order to attract new customers into the business. Okay. Got it. Well, thank you for taking my question.

Operator

Yes, thank you. Thanks, Ryan. Thanks, Ryan. Thank you. Our next question is from Linda Wiser with Water Tower Research.

Unknown Speaker

Hello. Hi, Terrence. Nice to be speaking with you again. Yes, hey, Linda. Good to hear you. So, my advantage in terms of the percentage of revenue that's outside of the Americas, it's really small, you know, relative to other direct selling companies. It seems to me that there could be an opportunity to expand the business a lot more outside the Americas. Is that kind of one of your first impressions? And if so, like, how would you prioritize that versus just kind of the things you want to do to the core business as it is now? Thanks. Okay.

Terrence Moorehead

Yes, I think you're right, Linda. I think clearly international is an opportunity. One of the things that attracted me to LifeVantage is that we're under-penetrated in all of our markets, not just internationally. So I think we have tremendous growth potential here in North America, but also internationally. So we will be moving forward to drive penetration in our kind of existing international markets. I don't know if we're going to expand our footprint further. you know, kind of immediately. I think we're best suited to drive penetration in a couple of anchor markets and then kind of branch out from there, almost in a kind of a hub and spoke type of approach.

But again, just given the scale of our business in North America, we want to take advantage of that. We want to leverage that, focus on on building out that team because we're still, like, we still have a lot of opportunity. And that would be kind of across categories and across, you know, kind of regions within the U.S.

Unknown Speaker

Okay. And then, Terrance, I know when you were at your previous company, you really leaned into driving e-commerce sales and and you really developed that business in the US in particular. Is that something that you see as an opportunity here too? And what are your thoughts?.

Terrence Moorehead

along those lines, thanks. I think that the opportunities at LifeVantage really focus on, certainly focus on, upgrading capabilities, building out digital capabilities, specifically building out our digital network. We'll see kind of where we take that, but first and foremost, I think we're going to kind of upgrade and update the consumer kind of access points. And so we have a fairly major kind of program to upgrade our website, upgrade our consumer experience. But then we're also going to kind of pair with that, upgrading the tools that we give to our sales force so that they can more effectively go to market in a much more effective and powerful manner with some digital tools in their hands and digital assets in their hands as well. So I definitely believe that digital is going to be a key strategy for us. We'll see how that unfolds. I think a big piece of the strategy also has to focus on being a much more consumer-centric company, being much more relevant to consumers so that we can be more effective on all fronts to improve and increase demand. That's how I'm looking at it right now.

Again, I'm still early days, so we need to see what our capabilities are and how we can move forward and how we can make sure that we have this kind of a very much integrated approach to our go-to-market strategy. So I hope that answers your question.

Unknown Speaker

Yes, thank you. Thank you. That's very helpful. And then my last question just has to do with, you know, The conversation so far has mentioned upgrades of IT, etc. So I'm just curious about any kind of very rough outlook about capital spending. It's a small percentage of revenue for the company, but it looks like it picked up a little bit in FY26. a year of increased spending in dollar terms, or just what do you think is going to be kind of the needed capital in that area? Thanks.

Unknown Speaker

You want to take that one? Yes, certainly. Yes, I can take that, Linda. And yes, you're right. Over the year over year increase over in the CapEx area, that was really all Shopify related and upgrading our e-commerce platform. We've made a lot of progress on that Shopify project to date. We're not done yet. We still have, you know, a little ways to go, but I would anticipate the total capex spend for FY27 to be slightly less than that number. And I think in total, we were around 3.7 million or so in fiscal 2026. I would anticipate it's more in the $3 to $3.5 million range as we close out the final stages of Shopify.

And once we're through that, then we're back down to normal capex spend, you know, back to the historical levels of the $2 to $2.5 million. Thank you, that's very helpful. Thanks very much.

Operator

Thanks. Thank you. This concludes our question and answer session. I'll now turn it back to Mr. Moorhead for any closing remarks.

Terrence Moorehead

Okay, well, thank you, everybody, for joining us today and for your continuous support. I look forward to talking to you again next quarter.

Operator

then take care. This concludes today's conference. You may disconnect your lines at this time. Thank you for your participation.

This live transcript is auto-generated without human intervention or review.

[Call has ended.]

면책 조항: 이 웹사이트에서 제공되는 정보는 교육적이고 정보 제공을 위한 목적으로만 사용되며, 금융 또는 투자 조언으로 간주되어서는 안 됩니다.

코멘트 (0)

$ 버튼을 클릭하고, 종목 코드를 입력한 후 주식, ETF 또는 기타 티커를 연결합니다.

0/500
코멘트 가이드라인
로딩 중...

추천 기사

tradingkey.logo
위험 경고: 저희 웹사이트와 모바일 앱은 특정 투자 상품에 대한 일반적인 정보만을 제공합니다. Finsights는 재정적 조언이나 투자 상품에 대한 추천을 제공하지 않으며, 이러한 정보 제공이 Finsights가 금융 조언이나 추천을 제공하는 것으로 해석되어서는 안 됩니다.
투자 상품은 투자 원금 손실을 포함한 상당한 투자 위험에 노출되어 있으며, 모든 사람에게 적합하지 않을 수 있습니다. 투자 상품의 과거 성과는 미래 성과를 보장하지 않습니다.
Finsights는 제3자 광고주나 제휴사가 저희 웹사이트나 모바일 앱 또는 그 일부에 광고를 게재하거나 전달할 수 있도록 허용할 수 있으며, 사용자가 광고와 상호작용하는 방식에 따라 이들로부터 보상을 받을 수 있습니다.
© 저작권: FINSIGHTS MEDIA PTE. LTD. 모든 권리 보유